Unexpected findings show that the body’s own immune system destroys retinal cells.
Glaucoma, a disease that afflicts nearly 70 million people worldwide, is something of a mystery despite its prevalence. Little is known about the origins of the disease, which damages the retina and optic nerve and can lead to blindness.
A new study from MIT and Massachusetts Eye and Ear has found that glaucoma may in fact be an autoimmune disorder. In a study of mice, the researchers showed that the body’s own T cells are responsible for the progressive retinal degeneration seen in glaucoma. Furthermore, these T cells appear to be primed to attack retinal neurons as the result of previous interactions with bacteria that normally live in our body.
The discovery suggests that it could be possible to develop new treatments for glaucoma by blocking this autoimmune activity, the researchers say.
“This opens a new approach to prevent and treat glaucoma,” says Jianzhu Chen, an MIT professor of biology, a member of MIT’s Koch Institute for Integrative Cancer Research, and one of the senior authors of the study, which appears in Nature Communications on Aug. 10.
Dong Feng Chen, an associate professor of ophthalmology at Harvard Medical School and the Schepens Eye Research Institute of Massachusetts Eye and Ear, is also a senior author of the study. The paper’s lead authors are Massachusetts Eye and Ear researchers Huihui Chen, Kin-Sang Cho, and T.H. Khanh Vu.
Genesis of glaucoma
One of the biggest risk factors for glaucoma is elevated pressure in the eye, which often occurs as people age and the ducts that allow fluid to drain from the eye become blocked. The disease often goes undetected at first; patients may not realize they have the disease until half of their retinal ganglion cells have been lost.
Most treatments focus on lowering pressure in the eye (also known as intraocular pressure). However, in many patients, the disease worsens even after intraocular pressure returns to normal. In studies in mice, Dong Feng Chen found the same effect.
“That led us to the thought that this pressure change must be triggering something progressive, and the first thing that came to mind is that it has to be an immune response,” she says.
To test that hypothesis, the researchers looked for immune cells in the retinas of these mice and found that indeed, T cells were there. This is unusual because T cells are normally blocked from entering the retina, by a tight layer of cells called the blood-retina barrier, to suppress inflammation of the eye. The researchers found that when intraocular pressure goes up, T cells are somehow able to get through this barrier and into the retina.
The Mass Eye and Ear team then enlisted Jianzhu Chen, an immunologist, to further investigate what role these T cells might be playing in glaucoma. The researchers generated high intraocular pressure in mice that lack T cells and found that while this pressure induced only a small amount of damage to the retina, the disease did not progress any further after eye pressure returned to normal.
Further studies revealed that the glaucoma-linked T cells target proteins called heat shock proteins, which help cells respond to stress or injury. Normally, T cells should not target proteins produced by the host, but the researchers suspected that these T cells had been previously exposed to bacterial heat shock proteins. Because heat shock proteins from different species are very similar, the resulting T cells can cross-react with mouse and human heat shock proteins.
To test this hypothesis, the team brought in James Fox, a professor in MIT’s Department of Biological Engineering and Division of Comparative Medicine, whose team maintains mice with no bacteria. The researchers found that when they tried to induce glaucoma in these germ-free mice, the mice did not develop the disease.
Human connection
The researchers then turned to human patients with glaucoma and found that these patients had five times the normal level of T cells specific to heat shock proteins, suggesting that the same phenomenon may also contribute to the disease in humans. The researchers’ studies thus far suggest that the effect is not specific to a particular strain of bacteria; rather, exposure to a combination of bacteria can generate T cells that target heat shock proteins.
One question the researchers plan to study further is whether other components of the immune system may be involved in the autoimmune process that gives rise to glaucoma. They are also investigating the possibility that this phenomenon may underlie other neurodegenerative disorders, and looking for ways to treat such disorders by blocking the autoimmune response.
“What we learn from the eye can be applied to the brain diseases, and may eventually help develop new methods of treatment and diagnosis,” Dong Feng Chen says.
Learn more: Study suggests glaucoma may be an autoimmune disease
The Latest on: Glaucoma
[google_news title=”” keyword=”glaucoma” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Glaucoma
- Glaucoma’s figures call for decisive actionon April 27, 2024 at 2:17 am
Diseases are bad news, and when one has gained notoriety like the way glaucoma is prevalent in Ghana, it calls for a lot of concern. Glaucoma remains one of the primary causes of blindness in the ...
- ASCRS 2024: Third-generation trabecular micro-bypass in eyes failing prior glaucoma therapyon April 26, 2024 at 12:09 pm
Deborah Gess Ristvedt, DO, shares highlights from her presentation and what these real-world cases mean for clinicians and their patients with glaucoma.
- BrightFocus Foundation Announces $10M in New Funding Across Brain and Vision Research, Celebrates Historic Diversity of Grant Award Recipientson April 24, 2024 at 11:00 pm
Global nonprofit BrightFocus Foundation announces $10 million in new Alzheimer’s disease, macular degeneration, and glaucoma research grant funding—age-related diseases with no cure that affect more ...
- Glaucoma care, fraught with many challenges, requires multifaceted approach — Experton April 24, 2024 at 7:31 pm
An ophthalmologist, Professor Affiong Ibanga, has said that glaucoma care in Nigeria is fraught with many challenges and requires a multifaceted approach ...
- Contact lenses may help diagnose glaucoma, claims studyon April 24, 2024 at 9:15 am
Glaucoma effects around 70 million people worldwide and can cause irreversible loss of vision if not treated-but around half of those living with the condition are not aware of it.
- Living with glaucoma: Tips for coping and maintaining visual health, quality of lifeon April 22, 2024 at 11:24 pm
Dr Akhilesh Sharma shared, “For screening of normal individuals for glaucoma since glaucoma does not present with any early warning signs in most cases, Ophthalmologists advise eye check-up at least ...
- Glaucoma: Worrying statistics cause for concernon April 21, 2024 at 6:50 pm
As the global population living with glaucoma surpasses 70 million, with over six million individuals blind from the condition, the situation ...
- Underweight, but Not Obesity, Linked to Glaucoma Progressionon April 21, 2024 at 5:00 pm
Opens in a new tab or window A higher body mass index (BMI) was significantly associated with slower rates of retinal nerve fiber layer change among patients with glaucoma, while those with ...
- Ginkgo Biloba – potential natural glaucoma treatmenton April 21, 2024 at 7:11 am
By Prof. Raphael Nyarkotey OBUQuaranta et al.(2003) found evidence that Ginkgo biloba may have a benefit in the treatment of glaucoma. Patients with Normal Tension Glaucoma (NGT) who were given 40mg ...
via Bing News